All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @captainbrootropic on TikTok · 25s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @captainbrootropic's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00people saying that some acts in Selink are really good and you'll focus for 12 hours
  2. 0:02it's a limitless bill but it's really not the limitless bill.
  3. 0:04Some acts at least only last for about 3 hours and you're only going to point 5 for most people
  4. 0:09and Selink only calms you down so unless you have a really bad anxiety support you can't
  5. 0:12start studying this, that won't really do anything for you.
  6. 0:14Right now I'm going to be running some atom actors that basically are a better version of
  7. 0:16some acts and bro maintains tomorrow and see if that really works.
  8. 0:19So if you want to see compounds that actually work and get an in-depth anecdote about how
  9. 0:22it works and if it's good or not I'll be posting to you about that tomorrow.

Are semax and selank actually useless? Sorting signal from hype

Capt. BioBro

TikTok creator

4.2K viewsWatch on TikTok

Quick answer

Semax and Selank are synthetic peptides with origins in Soviet-era neuroscience research, neither of which holds FDA approval for any indication. The creator's framing of Semax as short-acting and Selank as primarily anxiolytic reflects community consensus more than peer-reviewed pharmacokinetic data, which remains limited in healthy adult populations. Anyone considering these compounds should consult a licensed clinician, as compounded peptide formulations vary widely in purity, concentration, and stability.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 4 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Are semax and selank actually useless? Sorting signal from hype, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Are semax and selank actually useless? Sorting signal from hype is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Are semax and selank actually useless? Sorting signal from hype" from Capt. BioBro. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semax and Selank are synthetic peptides with origins in Soviet-era neuroscience research, neither of which holds FDA approval for any indication.

The reason this review is not generic is the source wording and the canonical claim label "peptides semax and selank are garebage peptide semax selank nootropic." In this clip, the useful excerpt is: "people saying that some acts in Selink are really good and you'll focus for 12 hours it's a limitless bill but it's really not the limitless bill." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Dolotov et al.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Semax and Selank are synthetic peptides with origins in Soviet-era neuroscience research, neither of which holds FDA approval for any indication.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semax and Selank are synthetic peptides with origins in Soviet-era neuroscience research, neither of which holds FDA approval for any indication. The creator's framing of Semax as short-acting and Selank as primarily anxiolytic reflects community consensus more than peer-reviewed pharmacokinetic data, which remains limited in healthy adult populations. Anyone considering these compounds should consult a licensed clinician, as compounded peptide formulations vary widely in purity, concentration, and stability.
  • Neither Semax nor Selank has FDA approval for any indication, and most human data comes from small Russian trials not yet independently replicated at scale.
  • Dolotov et al. (2011, Journal of Molecular Neuroscience) showed Semax increased BDNF and VEGF in rat models, but human cognitive duration data is not established in peer-reviewed literature.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Neither Semax nor Selank has FDA approval for any indication, and most human data comes from small Russian trials not yet independently replicated at scale.
  • Dolotov et al. (2011, Journal of Molecular Neuroscience) showed Semax increased BDNF and VEGF in rat models, but human cognitive duration data is not established in peer-reviewed literature.
  • Zozulya et al. (2014, Drug Design, Development and Therapy) documented both anxiolytic and memory-related effects for Selank, making the 'only calms you down' characterization an oversimplification.
  • Kolomin et al. (2019, Frontiers in Pharmacology) noted that peptide bioavailability and CNS penetration differ substantially by formulation and route, which matters when comparing compounded intranasal versus injectable versions.
  • The '3-hour duration' claim for Semax and the '0.5 dose' reference both lack cited pharmacokinetic sources and should not be used to guide personal use.
  • Self-experimentation documented on TikTok the following day is anecdote, not evidence, regardless of how detailed the creator's report turns out to be.
  • If you are curious about either peptide, start with a licensed clinician who can assess your individual health context, not a social media experiment with missing units and unnamed comparison compounds.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @captainbrootropic actually say?

The creator pushed back on hype around Semax and Selank, calling them overstated. Their core argument: Semax only lasts about 3 hours at a 0.5 dose, and Selank "only calms you down" rather than boosting cognition. They concluded that unless you have severe anxiety blocking your study sessions, Selank "won't really do anything for you." They then teased a pivot to something they called "atom actors" as a supposedly better alternative.

That summary is actually more measured than the average nootropic TikTok, which usually opens with someone claiming a peptide rewired their brain. Credit where it is due: they explicitly rejected the "limitless pill" framing. But several of their specific claims need scrutiny, and the casual dismissal of Selank deserves a harder look than they gave it.

Does the science back this up?

Partially, yes. The duration claim for Semax has some basis, though the evidence is thinner than most Reddit threads suggest. The characterization of Selank as purely anxiolytic is where things get complicated.

Semax is a synthetic analogue of ACTH(4-7) developed in Russia. Most of the controlled research on cognitive effects comes from Russian-language trials with small sample sizes. A 2011 study by Dolotov et al. in the Journal of Molecular Neuroscience demonstrated Semax increased BDNF and VEGF expression in rat models. Human duration data is sparse. The "3-hour window" circulating in nootropic communities is largely anecdotal, not from controlled pharmacokinetic trials in healthy adults.

Selank is an anxiolytic peptide derived from tuftsin, also developed in Russia. A 2014 study by Zozulya et al. in the Drug Design, Development and Therapy journal found Selank reduced anxiety and showed some nootropic properties, including effects on memory consolidation. Calling it strictly a calmative undersells its documented mechanism. It modulates GABAergic transmission and influences BDNF expression, which is not nothing from a learning standpoint.

What did they get wrong (or right)?

They got the anti-hype framing right. Semax is not a limitless pill. That is accurate. Where they went wrong is the confident claim that Selank "only calms you down." That is an oversimplification that ignores its documented effects on cognitive flexibility and memory in anxious populations.

The 0.5 dose claim is presented without units, which is a real problem. 0.5 what? Milligrams? Micrograms? Intranasal Semax is typically measured in micrograms per spray. Without units, that number is meaningless as practical information, and for a regulated telehealth context, presenting dosing information without clinical guidance is exactly the kind of shortcut that gets people into trouble.

The creator also conflates "only works for anxious people" with "does nothing for you." That is not how anxiolytic nootropics work in the literature. If anxiety is impairing working memory, reducing that anxiety improves cognitive output. That is a clinically relevant mechanism, not a consolation prize. Zozulya et al. (2014) documented this pathway specifically.

What should you actually know?

Both Semax and Selank remain investigational compounds. Neither has FDA approval. Most clinical data comes from Russian trials that are difficult to independently replicate or access in full. That does not make them useless, but it does mean personal anecdote, including from TikTok creators running "experiments" on themselves, is not a substitute for clinical guidance.

If you are considering either peptide, the route of administration matters significantly. Intranasal delivery has different bioavailability than injectable forms. A 2019 review by Kolomin et al. in Frontiers in Pharmacology noted that peptide stability and CNS penetration vary substantially by formulation and route, which is exactly why compounded versions sourced without medical oversight are a real concern.

The creator's plan to try something they called "atom actors" and report back tomorrow is a personal experiment, not clinical evidence. Entertaining, maybe. Useful as health guidance? No.

Bottom line

This video is less harmful than most peptide content because it rejects obvious hype. But the dismissal of Selank as purely anxiolytic is too blunt, the duration claim for Semax lacks sourced pharmacokinetic backing, and the dosing language is sloppy in ways that matter. If you are curious about either compound, this video is a reasonable starting point for skepticism, not a roadmap for use.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Capt. BioBro · TikTok creator

4.2K views on this video

SEMAX AND SELANK ARE GAREBAGE?? #peptide #semax #selank #nootropics #studying

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about neither semax nor selank has fda approval for any indication,?

Neither Semax nor Selank has FDA approval for any indication, and most human data comes from small Russian trials not yet independently replicated at scale.

Dolotov et al. (2011, Journal of Molecular Neuroscience) showed Semax increased BDNF and VEGF in rat models, but human cognitive duration data is not established in peer-reviewed literature?

Dolotov et al. (2011, Journal of Molecular Neuroscience) showed Semax increased BDNF and VEGF in rat models, but human cognitive duration data is not established in peer-reviewed literature.

What does the video say about zozulya et al. (2014, drug design, development?

Zozulya et al. (2014, Drug Design, Development and Therapy) documented both anxiolytic and memory-related effects for Selank, making the 'only calms you down' characterization an oversimplification.

What does the video say about kolomin et al. (2019, frontiers in pharmacology) noted?

Kolomin et al. (2019, Frontiers in Pharmacology) noted that peptide bioavailability and CNS penetration differ substantially by formulation and route, which matters when comparing compounded intranasal versus injectable versions.

What does the video say about the '3-hour duration' claim for semax?

The '3-hour duration' claim for Semax and the '0.5 dose' reference both lack cited pharmacokinetic sources and should not be used to guide personal use.

What does the video say about self-experimentation documented on tiktok the following day?

Self-experimentation documented on TikTok the following day is anecdote, not evidence, regardless of how detailed the creator's report turns out to be.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Capt. BioBro, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.